XML 238 R37.htm IDEA: XBRL DOCUMENT v3.22.0.1
Operating Assets and Liabilities - Deferred Revenue (Details)
$ in Millions
1 Months Ended 12 Months Ended
Jun. 10, 2020
Jul. 31, 2020
DKK (kr)
Jul. 31, 2020
USD ($)
Dec. 31, 2021
DKK (kr)
Dec. 31, 2020
DKK (kr)
Dec. 31, 2019
DKK (kr)
Disclosure of disaggregation of revenue from contracts with customers [line items]            
Revenue recognized during the year       kr (8,482,000,000) kr (10,111,000,000) kr (5,366,000,000)
Upfront payment recognized       8,482,000,000 10,111,000,000 kr 5,366,000,000
AbbVie            
Disclosure of disaggregation of revenue from contracts with customers [line items]            
Deferred revenue at January 1       513,000,000    
Payment received         4,911,000,000  
Revenue recognized during the year       (245,000,000) (4,398,000,000)  
Total at December 31       513,000,000 513,000,000  
Non-current deferred revenue       487,000,000 487,000,000  
Current deferred revenue       26,000,000 26,000,000  
Deferred Revenue Recognized       0 0  
Total at December 31       513,000,000 513,000,000  
Upfront payment   kr 4,911,000,000 $ 750      
Upfront payment recognized       0 4,398,000,000  
Revenue from performance obligations satisfied or partially satisfied in previous periods       kr 0 kr 0  
Performance Obligation Revenue Recognition Period 7 years     7 years